Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

NCT02762266 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Business decision - funding

Conditions

Child-Pugh Class A
Child-Pugh Class B
Recurrent Hepatocellular Carcinoma

Interventions

RADIATION: Stereotactic Body Radiation Therapy
PROCEDURE: Transarterial Chemoembolization
DRUG: embolic agent
DRUG: lipiodol

Sponsor

Stanford University

Collaborators

[object Object]